These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26550182)

  • 1. Lack of association between cyclin D1 A870G (rs9344) polymorphism and esophageal squamous cell carcinoma risk: case-control study and meta-analysis.
    Tang W; Yu P; Wang Y; Kang M; Sun B; Yin J; Gu H
    Int J Clin Exp Med; 2015; 8(8):12685-95. PubMed ID: 26550182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The association of cyclin D1 (A870G) polymorphism with susceptibility to esophageal and cardiac cancer in north Chinese population].
    Wang R; Zhang JH; Li Y; Wen DG; He M; Wei LZ
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1089-92. PubMed ID: 12899785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
    Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT
    Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.
    Schernhammer ES; Tranah GJ; Giovannucci E; Chan AT; Ma J; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
    Br J Cancer; 2006 Mar; 94(6):928-34. PubMed ID: 16495921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphism of
    He W; Zeng Y; Long J; Zhou Q; Hu Y; Chen M
    Biomed Rep; 2013 Mar; 1(2):303-307. PubMed ID: 24648939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk.
    Liu LC; Su CH; Wang HC; Chang WS; Tsai CW; Maa MC; Tsai CH; Tsai FJ; Bau DT
    Biomedicine (Taipei); 2014; 4(1):3. PubMed ID: 25520916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
    Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
    Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.
    Zheng M; Wan L; He X; Qi X; Liu F; Zhang DH
    World J Surg Oncol; 2015 Feb; 13():55. PubMed ID: 25888980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between cytotoxic T-lymphocyte antigen 4 (CTLA-4) -1722T/C (rs733618) polymorphism and cancer risk: from a case-control study to a meta-analysis.
    Tang W; Qiu H; Jiang H; Sun B; Wang L; Yin J; Gu H
    PLoS One; 2014; 9(4):e94039. PubMed ID: 24710335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significant association of CCND1 genotypes with colorectal cancer in Taiwan.
    Huang CY; Tsai CW; Hsu CM; Chang WS; Shui HA; Bau DT
    Tumour Biol; 2015 Aug; 36(8):6533-40. PubMed ID: 25809706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer.
    Cakina S; Gulyasar T; Ozen A; Sipahi T; Kocak Z; Sener S
    Indian J Biochem Biophys; 2013 Jun; 50(3):233-6. PubMed ID: 23898488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of
    Qiu H; Cheng C; Wang Y; Kang M; Tang W; Chen S; Gu H; Liu C; Chen Y
    Onco Targets Ther; 2016; 9():6641-6650. PubMed ID: 27822068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
    Forones NM; de Lima JM; de Souza LG; da Silva ID
    J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
    Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
    Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.
    Koike H; Suzuki K; Satoh T; Ohtake N; Takei T; Nakata S; Yamanaka H
    Anticancer Res; 2003; 23(6D):4947-51. PubMed ID: 14981950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.